Treatment of primary syphilis.
Reports in the English language of the treatment of primary syphilis are reviewed. Except for benzathine penicillin, the efficacy of the currently recommended dosage schedules are documented only by Schroeter et al. Although these investigators reported generally acceptable failure rates, further study is necessary to determine: (1) if differences in efficacy exist among regimes; (2) if the current schedules are equally effective in both primary and secondary syphilis; and (3) if increased dosages reduce failure rates.
D002511:Cephalosporins / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D005079:Excipients; D006801:Humans; D010401:Penicillin G Benzathine / Q000627:therapeutic use; D010402:Penicillin G Procaine / Q000627:therapeutic use; D013587:Syphilis / Q000188:drug therapy*; D013754:Tetracyclines / Q000627:therapeutic use
D002511:Cephalosporins; D005079:Excipients; D013754:Tetracyclines; D010402:Penicillin G Procaine; D004917:Erythromycin; D002701:Chloramphenicol; D010401:Penicillin G Benzathine